Vaccine available only by phase

February 2, 2021 Providence News Team

IMPORTANT NOTE: We know there is high interest in people wanting a COVID vaccine. Please know that vaccines are not currently available at Providence clinics and we are not scheduling appointments. We will update this website as we know more information about vaccine availability.

This is the best way to find out the most current information. We’d ask you to please not call clinics, hospitals and other health care providers at this time to ask about vaccines. Our phone centers are overwhelmed and we need to focus on our patients who need care.

Here’s some updated information (as of Feb. 2, 2021):

Oregon Governor Kate Brown and the Oregon Health Authority have said they hope to open vaccines to people older than 80 on Feb. 8. We will let you know as soon as we can about when and how to schedule your vaccination.
Some of the smaller communities around Oregon have completed vaccinations for all people in the 1A category and teachers, and have moved on to vaccinating older adults. You also may be seeing that Washington and many other states are vaccinating older adults, based on the priorities for their communities. We continue to follow direction from Governor Brown and the OHA.
Providence, Legacy, OHSU and Kaiser Permanente health systems have joined to create a mass vaccination clinic at the Oregon Convention Center. This location is intended to vaccinate tens of thousands of Oregonians. At this time, several thousand vaccinations are being given daily to predominantly teachers and staff; the mass vaccination clinic is limited by the number of vaccines we receive.

We do not know when more vaccines will be available or when the governor and OHA will expand who is able to receive the COVID vaccine. Please know that we will continue to update this site as more information is announced.

For more information, please check the following websites:

Vaccines are being made available by phase. When Oregon Health Authority releases additional vaccination phases, we will post this information on our website, coronavirus.providence.org/or-updates.
For more information about the phases, see this outline from OHA.
For more information from Oregon Health Authority on vaccines by county, see, https://www.oregon.gov/oha/covid19/Pages/vaccine-information-by-county.aspx
For more general information on COVID from the Oregon Health Authority, see https://govstatus.egov.com/OR-OHA-COVID-19.

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Welcome to your journey for creating a healthier you

Vaccine available only by phase

About the Author

Previous Article

Next Article

Vaccine available only by phase

About the Author

Previous Article

Next Article

Other content in this Stream

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Please revert to normal e-prescribing workflows and stop using paper prescriptions.

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

Supporting thousands of patients experiencing food insecurity, a converted space at Providence Gateway Internal Medicine clinic is filled with fresh fruits and vegetables, meat, milk, eggs and more.

Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.

In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.

Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy

Providence and Regence have reached an agreement to continue care delivery services together.

"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

The Oregon Health Authority has selected the Portland, Oregon-based Center for Outcomes Research & Education (CORE) to create an evaluation design for Oregon's 2022-2027 1115 Medicaid waiver.

Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.

Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.